Media Room - page 9

10 March 2017

Perfomance of a Radiation Protection Cabin during extraction of cardiac devices

The cabin offers nearly full body radioprotection and eliminates the need to wear a lead apron, without increasing procedural time or complication rate during cardiac device extraction.

22 February 2017

Pr. Kazutaka Aonuma

“Cathpax® has become one of the most necessary devices in my lab, especially when performing complicated cases such as atrial fibrillation ablations and substrate-guided ventricular tachycardia ablations, where a longer procedure time is usually required. From the whole body protection...

3 February 2017

Epijet® on track for success

At the most recent congress of the Spanish Epilepsy Society and at the EANM, Epijet® has attracted much interest from nuclear medicine specialists and neurologists.

25 January 2017

Gamma protection

Lemer Pax and Matisec have joined forces to produce a ventilated, radioprotective suit which offers optimal protection against gamma radiation.

thumbnail picture testimony julie vialard en

17 January 2017

Julie Vialard-Miguel

“Following a medical device vigilance warning on our PET injector, we contacted Lemer Pax to set up a 3-month rent contract for a Posijet® V3. Lemer Pax proved to be very reactive and flexible to satisfy our pressing demand. The...

7 January 2017

Headed for Argentina

Lemer Pax inspection windows cross the Atlantic

18 December 2016

CEA Tech and Lemer Pax join forces for a new facility with strategic significance for industrial competitiveness

Lemer Pax recently create a new lead-lined bunker for CEA Tech, designed for non-destructive testing. A sure-fire source of value added for the region and the sector.

18 November 2016

Dr. Bernhard Strohmer

“The use of the Cathpax® cabin turned out to be one of the most important achievements in my daily EP practice as far as radioprotection is concerned. The cabin is no hindrance at all for handling the catheters and the...

10 November 2016

Orano Med and Lemer Pax: a partnership built to last

A consortium committed to demonstrating the benefits of Lead-212 for cancer treatment, and launching production on an industrial scale.

30 October 2016

Martin Pappon

“The nuclear medicine operators are using Posijet everyday. They appreciate: the system ease-of-use, the reduced-time for dose preparation, the possibility to remain close to the patient during dose preparation, the motorisation (so easy to manoeuvre), the minimized exposure to radiations...

25 October 2016

Lemer Pax and Medisystem, working hand-in-hand

Closer collaboration, symbiosis and an expanded range of solutions!

14 October 2016

Dedicated to protecting the environment

Lemer Pax’s ecological commitments are reflected in our approach to collaborative projects

8 October 2016

Pr. Robert Hatala

“Radiation exposure is a truly vital issue for all interventional electrophysiologists. Deployment of non-fluoroscopic mapping techniques in the last decade helped to achieve significant radiation reduction. Nevertheless, fluoroscopy remains the key non-virtual imaging tool in several areas: for cryoballon pulmonary...

3 October 2016

Lemer Pax gets a makeover

Lemer Pax’s new visual identity (developed in partnership with Parisian PR agency Evolve) and the light, spacious elegance of our new premises at La Chapelle (designed by architectural firm Topos) reflect the fundamental identity of our company: collaborative spirit, open...

5 September 2016

NEG, Japanese spring on the banks of the Loire

A commitment to the long term is something we share with our Japanese partners. Over the years we’ve developed an excellent relationship with the directors of (Nippon Electric Glass), a business partnership enriched by a sense of mutual trust.

CP_Groupe Confluent and Lemer Pax partners

9 May 2016

New nuclear medicine system: Lemer Pax Partners with Confluent Group

After being operational partners for several years, Confluent and Lemer Pax have decided to officialise their partnership. Lemer Pax is providing the hospital with the new generation Posijet® radiopharmaceutical injection system for 3 months. The test phase will demonstrate the...